Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03878030 · ClinicalTrials.gov registry record
Effect of Nusinersen on Adults With Spinal Muscular Atrophy
A clinical trial of Adult Spinal Muscular Atrophy, sponsored by Northwell Health.
- Completed
- Registry status
- 12
- Enrollment target
- 1
- Study location
NCT03878030 is a study of Adult Spinal Muscular Atrophy that has completed, run by Northwell Health. The registered enrollment target is 12 participants. The trial reports 1 study location across 1 state.
The verdict
NCT03878030, a study of Adult Spinal Muscular Atrophy, has completed, sponsored by Northwell Health.
- COMPLETED
- Registry status
- 12 participants
- Enrollment target
- 1
- Study location
Study Summary
Observational study of adult patients with spinal muscular atrophy types 2 and 3 receiving nusinersen
Conditions Studied
Interventions
- DRUG nusinersen
Study Locations (1)
New York
- Northwell Health Neuroscience - Great Neck
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2019-04-01 |
| Est. Completion | 2021-07-13 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03878030
The ClinicalTrials.gov registry entry for NCT03878030 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Northwell Health, which has 370 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Adult Spinal Muscular Atrophy appearing as the primary indexed condition, and to 1 intervention - of which nusinersen is the first listed.
NCT03878030 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT03878030 about?
NCT03878030 is a clinical study titled "Effect of Nusinersen on Adults With Spinal Muscular Atrophy". Observational study of adult patients with spinal muscular atrophy types 2 and 3 receiving nusinersen
What is the current status of trial NCT03878030?
This trial is currently completed. The enrollment target is 12 participants. The study started on 2019-04-01. Estimated completion is 2021-07-13.
What conditions does trial NCT03878030 study?
This clinical trial studies the following conditions: Adult Spinal Muscular Atrophy.
What interventions are being tested in trial NCT03878030?
The interventions under investigation include: nusinersen (DRUG).
Who is sponsoring clinical trial NCT03878030?
This trial is sponsored by Northwell Health, which has 370 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03878030 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.